Gastrocrom and Dizziness aggravated - a phase IV clinical study of FDA data

Summary:

Dizziness aggravated is reported as a side effect among people who take Gastrocrom (cromolyn sodium), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Vitamin D3, and have Narcolepsy.

The phase IV clinical study analyzes which people have Dizziness aggravated when taking Gastrocrom. It is created by eHealthMe based on reports of 244 people who have side effects when taking Gastrocrom from the FDA, and is updated regularly.

What is Gastrocrom?

Gastrocrom has active ingredients of cromolyn sodium. eHealthMe is studying from 255 Gastrocrom users. Check the latest studies of Gastrocrom.

What is Dizziness aggravated?

Dizziness aggravated is found to be associated with 2,725 drugs and 970 conditions by eHealthMe. Check the latest studies of Dizziness aggravated.

On Jul, 03, 2026

244 people reported to have side effects when taking Gastrocrom.
Among them, 25 people (10.25%) have Dizziness aggravated.

Could Gastrocrom cause Dizziness aggravated?

Among these 25 people:

How long have people been on Gastrocrom when they have Dizziness aggravated? *

What is the gender of people who have Dizziness aggravated when taking Gastrocrom? *

female: 88 %
male: 12 %

What is the age of people who have Dizziness aggravated when taking Gastrocrom? *

What are other drugs people take besides Gastrocrom? *

What are other side effects people have besides Dizziness aggravated? *

Stress And Anxiety: 16 people, 64.00%
Fatigue (feeling of tiredness): 14 people, 56.00%
Memory Loss: 12 people, 48.00%
Pain: 10 people, 40.00%
Nausea (feeling of having an urge to vomit): 10 people, 40.00%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 32.00%
Abdominal Discomfort: 7 people, 28.00%
Dyspnea (difficult or laboured breathing): 6 people, 24.00%
Face Injury: 6 people, 24.00%
Post-Traumatic Stress Disorder: 6 people, 24.00%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 17 people, 68.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 16 people, 64.00%
Stress And Anxiety: 4 people, 16.00%
Drowsiness: 4 people, 16.00%
Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 3 people, 12.00%
Urticaria Pigmentosa (skin disease that produces patches of darker skin (lesions) and very bad itching): 1 person, 4.00%
Sleep Disorder: 1 person, 4.00%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 4.00%
Movement - Uncoordinated: 1 person, 4.00%
Malignant Mast Cell Neoplasm (cancerous tumour of mast cell (immune cell)): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Gastrocrom and have Dizziness aggravated?

- Check whether Dizziness aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gastrocrom:

Gastrocrom (255 reports)

Browse all side effects of Gastrocrom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness aggravated:

Dizziness aggravated (2,725 drugs)

Browse all the conditions that are associated with Dizziness aggravated:

Dizziness aggravated (970 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cromolyn sodium (the active ingredients of Gastrocrom) and Gastrocrom (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.